Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Heterologous and BNT162b2 boosters are more effective than non-mRNA homologous boosters for Omicron.
J Infect. 2024 Jun;88(6):106165. doi: 10.1016/j.jinf.2024.106165. Epub 2024 Apr 24.
J Infect. 2024.
PMID: 38670269
Free article.
No abstract available.
Comparative effectiveness and duration of protection of ChAdOx1, CoronaVac, BNT162b2, mRNA-1273, and Ad26.COV2.S COVID-19 vaccines for symptomatic and hospitalized Mu, Delta, and Omicron: A test-negative case-control study.
Paternina-Caicedo A, Quevedo DS, Ríos DS, Moyano D, Alvis-Guzmán N, Alviz-Zakzuk NR, Salcedo F, Moyano L, Ramírez-Suarez J, Smith AD, De la Hoz-Restrepo F.
Paternina-Caicedo A, et al. Among authors: alviz zakzuk nr.
Vaccine. 2023 Oct 6;41(42):6291-6299. doi: 10.1016/j.vaccine.2023.08.072. Epub 2023 Sep 9.
Vaccine. 2023.
PMID: 37679278
Item in Clipboard
Cite
Cite